Mancini Anthony sold $3.2M of RVMD
Mancini Anthony (See Remarks) sold 15,448 shares of Revolution Medicines, Inc. (RVMD) at an average of $204.16 ($203.28–$207.17, $3.15M total) across 5 trades on 2026-09-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The filing provides the first public disclosure of this officer's sale, offering a data point for monitoring insider activity.
Market read
Insider sale is a modest, low‑impact event; traders may watch for any follow‑up activity.
What to watch
Potential upcoming clinical data releases could outweigh the insider sale effect.
Background
Revolution Medicines (RVMD) is a clinical‑stage biotech focused on oncology therapies.
Ticker impact
Officer Mancini Anthony sold 15,448 shares for $3.15M via a 10b5‑1 plan on Sep 10, reducing his stake to 43,890 shares.
Modest short‑term dip, likely within 1‑2% range.
Sale size is modest relative to market cap; insider is an officer, but the transaction follows a pre‑arranged plan, limiting informational value.
Market effects
Minimal impact on biotech sector; no broader industry signal.
None
None
Counterpoint
The sale could be a routine liquidity move; investors may ignore it.
Key entities
- OfficerMancini Anthony
Officer of Revolution Medicines who executed the sale.
- CompanyRevolution Medicines, Inc.
Biotech firm whose stock may react to insider transactions.
